相关实验视频

Updated: May 12, 2026

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

68Ga-DOTA-FAPI-04的摄入量在妇产不适的情况下

Tingting Xu, Feiyu Zhang, Shiyu Zheng

Clinical nuclear medicine

|August 28, 2024

概括

一名患有恶性黑色素瘤的男性在右乳房显示68 Ga-DOTA-FAPI-04 PET/CT的吸收增加. 然而,超声检查显示了良性妇产不良,而不是恶性.

科学领域:

在瘤学瘤学.
核医学是一种核医学.
放射学放射学是一门学科.

背景情况:

恶性黑色素瘤可以转移到各种器官.
用新型标记剂的正子发射断层扫描/计算机断层扫描 (PET/CT) 有助于癌症检测.
纤维细胞激活蛋白 (FAPI) 向的PET/CT正在癌症成像中出现.

研究的目的:

在PET/CT.上报告怀疑乳腺恶性瘤的病例.
评估68 Ga-DOTA-FAPI-04 PET/CT在黑色素瘤患者中的功效.
为了区分乳房中的恶性和良性疾病.

主要方法:

一个男性患者的病例介绍,他有恶性黑色素瘤病史.
使用68 Ga-DOTA-FAPI-04 PET/CT进行成像.
进行诊断超声波以进一步表征.

主要成果:

68 Ga-DOTA-FAPI-04 PET/CT扫描显示右乳房的标记物吸收增加,这表明恶性瘤.
超声波检查显示乳腺组织变厚,没有恶性瘤的证据.
这些发现与良性妇产不良一致.

结论:

68 Ga-DOTA-FAPI-04 PET/CT可以在良性乳腺疾病中显示增加的吸收.
诊断性超声波对于区分良性与恶性乳腺病变至关重要.
在有癌症病史的患者中,需要仔细对成像检测结果进行关联.

更多相关视频

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

An Automated Radiosynthesis of [⁶⁸Ga]Ga-FAPI-46 for Routine Clinical Use

Published on: May 24, 2024

相关概念视频

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...